We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Better chance of survival for people with rare cancers thanks to a new government approach to clinical trials and access to breakthrough treatments
Estimated proportion of all malignant cancers where patients first presented as an emergency.
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Projects granted during 2016 that have a primary purpose of translational and applied research - human cancer.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Information on depleted uranium (DU) including what it is, its uses, health effects and protection from exposure.
Projects granted during 2015 that have a primary purpose of basic research: oncology.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).